APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enoxaparin Sodium

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Selected research

Industry Growth & Trends

Global Enoxaparin Sodium Industry Growth and Trends Forecast to 2032

30 December 2025120 pages

Choose your research edition.

Industry ResearchEnoxaparin Sodium Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Enoxaparin Sodium Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Enoxaparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enoxaparin Sodium Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Enoxaparin Sodium Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in this market.Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and some others are playing important roles in Enoxaparin sodium injection industry. Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi are the top 5 players of Enoxaparin Sodium, with about 85% market shares.

There are nine different dosage form of Enoxaparin Sodium. The market can be segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL. 40 mg/0.4mL is almost the only used and efficient types and took 40% market share. By application, Hospital is the largest consumer group, with market share of 63%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Enoxaparin Sodium market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Enoxaparin Sodium market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Enoxaparin Sodium market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Enoxaparin Sodium.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Enoxaparin Sodium market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Enoxaparin Sodium Market by Company

Sanofi

Teva

Techdow (Hepalink)

Fresenius Kabi

Rovi

Amphastar

Nanjing King-friend

Sandoz

Apotex

Hangzhou Jiuyuan Gene Engineering

Cipla

Taj Pharma

Chengdu Baiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Changzhou Qianhong Bio-pharma

Hebei Changshan Biochemical Pharmaceutical

Beijing SL Pharmaceutical

Huadong Medicine

Bharat Serums

INTAS

LUPIN

Troikaa Pharmaceuticals

Aristopharma

Fosun Pharma

SciencePharma

PISA

Enoxaparin Sodium Segment by Type

20 mg/0.2mL

30 mg/0.3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

300mg/3mL

Enoxaparin Sodium Segment by Application

Hospital

Clinic

Others

Enoxaparin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Enoxaparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 20 mg/0.2mL Table 2. Major Company of 30 mg/0.3mL Table 3. Major Company of 40 mg/0.4mL Table 4. Major Company of 60 mg/0.6mL Table 5. Major Company of 80 mg/0.8mL Table 6. Major Company of 100 mg/1mL Table 7. Major Company of 120 mg/0.8mL Table 8. Major Company of 150 mg/1mL Table 9. Major Company of 300mg/3mL Table 10. Global Enoxaparin Sodium Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 11. Global Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 12. Global Enoxaparin Sodium Sales Market Share in Volume by Type (2021-2026) Table 13. Global Enoxaparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 14. Global Enoxaparin Sodium Sales Market Share in Value by Type (2021-2026) Table 15. Global Enoxaparin Sodium Price by Type (2021-2026) & (US$/Unit) Table 16. Global Enoxaparin Sodium Sales by Type (2027-2032) & (M Units) Table 17. Global Enoxaparin Sodium Sales Market Share in Volume by Type (2027-2032) Table 18. Global Enoxaparin Sodium Sales by Type (2027-2032) & (US$ Million) Table 19. Global Enoxaparin Sodium Sales Market Share in Value by Type (2027-2032) Table 20. Global Enoxaparin Sodium Price by Type (2027-2032) & (US$/Unit) Table 21. North America Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 22. North America Enoxaparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 23. Europe Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 24. Europe Enoxaparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 25. Asia-Pacific Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 26. Asia-Pacific Enoxaparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 27. Latin America Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 28. Latin America Enoxaparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 29. Middle East and Africa Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 30. Middle East and Africa Enoxaparin Sodium Sales by Type (2021-2026) & (US$ Million) Table 31. Enoxaparin Sodium Industry Trends Table 32. Enoxaparin Sodium Industry Drivers Table 33. Enoxaparin Sodium Industry Opportunities and Challenges Table 34. Enoxaparin Sodium Industry Restraints Table 35. Global Enoxaparin Sodium Sales Revenue by Company (US$ Million) & (2021-2026) Table 36. Global Enoxaparin Sodium Revenue Market Share by Company (2021-2026) Table 37. Global Enoxaparin Sodium Sales by Company (2021-2026) & (M Units) Table 38. Global Enoxaparin Sodium Sales Share by Company (2021-2026) Table 39. Global Enoxaparin Sodium Market Price by Company (2021-2026) & (US$/Unit) Table 40. Global Enoxaparin Sodium Industry Company Ranking, 2024 VS 2025 VS 2026 Table 41. Global Enoxaparin Sodium Major Company Production Sites and Headquarters Table 42. Global Enoxaparin Sodium Company, Product Type & Application Table 43. Global Enoxaparin Sodium Company Establishment Date Table 44. Global Company Market Concentration Ratio (CR5 and HHI) Table 45. Global Enoxaparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 46. Global Enoxaparin Sodium Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 47. Global Enoxaparin Sodium Sales by Region (2021-2026) & (M Units) Table 48. Global Enoxaparin Sodium Sales Market Share in Volume by Region (2021-2026) Table 49. Global Enoxaparin Sodium Sales by Region (2021-2026) & (US$ Million) Table 50. Global Enoxaparin Sodium Sales Market Share in Value by Region (2021-2026) Table 51. Global Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 52. Global Enoxaparin Sodium Sales by Region (2027-2032) & (M Units) Table 53. Global Enoxaparin Sodium Sales Market Share in Volume by Region (2027-2032) Table 54. Global Enoxaparin Sodium Sales by Region (2027-2032) & (US$ Million) Table 55. Global Enoxaparin Sodium Sales Market Share in Value by Region (2027-2032) Table 56. Global Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 57. Global Enoxaparin Sodium Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 58. Global Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 59. Global Enoxaparin Sodium Sales Market Share in Volume by Application (2021-2026) Table 60. Global Enoxaparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 61. Global Enoxaparin Sodium Sales Market Share in Value by Application (2021-2026) Table 62. Global Enoxaparin Sodium Price by Application (2021-2026) & (US$/Unit) Table 63. Global Enoxaparin Sodium Sales by Application (2027-2032) & (M Units) Table 64. Global Enoxaparin Sodium Sales Market Share in Volume by Application (2027-2032) Table 65. Global Enoxaparin Sodium Sales by Application (2027-2032) & (US$ Million) Table 66. Global Enoxaparin Sodium Sales Market Share in Value by Application (2027-2032) Table 67. Global Enoxaparin Sodium Price by Application (2027-2032) & (US$/Unit) Table 68. North America Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 69. North America Enoxaparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 70. Europe Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 71. Europe Enoxaparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 72. Asia-Pacific Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 73. Asia-Pacific Enoxaparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 74. Latin America Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 75. Latin America Enoxaparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 76. Middle East and Africa Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 77. Middle East and Africa Enoxaparin Sodium Sales by Application (2021-2026) & (US$ Million) Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sanofi Enoxaparin Sodium Product Portfolio Table 82. Sanofi Recent Development Table 83. Teva Company Information Table 84. Teva Business Overview Table 85. Teva Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Teva Enoxaparin Sodium Product Portfolio Table 87. Teva Recent Development Table 88. Techdow (Hepalink) Company Information Table 89. Techdow (Hepalink) Business Overview Table 90. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Techdow (Hepalink) Enoxaparin Sodium Product Portfolio Table 92. Techdow (Hepalink) Recent Development Table 93. Fresenius Kabi Company Information Table 94. Fresenius Kabi Business Overview Table 95. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Fresenius Kabi Enoxaparin Sodium Product Portfolio Table 97. Fresenius Kabi Recent Development Table 98. Rovi Company Information Table 99. Rovi Business Overview Table 100. Rovi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Rovi Enoxaparin Sodium Product Portfolio Table 102. Rovi Recent Development Table 103. Amphastar Company Information Table 104. Amphastar Business Overview Table 105. Amphastar Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Amphastar Enoxaparin Sodium Product Portfolio Table 107. Amphastar Recent Development Table 108. Nanjing King-friend Company Information Table 109. Nanjing King-friend Business Overview Table 110. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Nanjing King-friend Enoxaparin Sodium Product Portfolio Table 112. Nanjing King-friend Recent Development Table 113. Sandoz Company Information Table 114. Sandoz Business Overview Table 115. Sandoz Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Sandoz Enoxaparin Sodium Product Portfolio Table 117. Sandoz Recent Development Table 118. Apotex Company Information Table 119. Apotex Business Overview Table 120. Apotex Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Apotex Enoxaparin Sodium Product Portfolio Table 122. Apotex Recent Development Table 123. Hangzhou Jiuyuan Gene Engineering Company Information Table 124. Hangzhou Jiuyuan Gene Engineering Business Overview Table 125. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio Table 127. Hangzhou Jiuyuan Gene Engineering Recent Development Table 128. Cipla Company Information Table 129. Cipla Business Overview Table 130. Cipla Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Cipla Enoxaparin Sodium Product Portfolio Table 132. Cipla Recent Development Table 133. Taj Pharma Company Information Table 134. Taj Pharma Business Overview Table 135. Taj Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Taj Pharma Enoxaparin Sodium Product Portfolio Table 137. Taj Pharma Recent Development Table 138. Chengdu Baiyu Pharmaceutical Company Information Table 139. Chengdu Baiyu Pharmaceutical Business Overview Table 140. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio Table 142. Chengdu Baiyu Pharmaceutical Recent Development Table 143. Suzhou Erye Pharmaceutical Company Information Table 144. Suzhou Erye Pharmaceutical Business Overview Table 145. Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio Table 147. Suzhou Erye Pharmaceutical Recent Development Table 148. Changzhou Qianhong Bio-pharma Company Information Table 149. Changzhou Qianhong Bio-pharma Business Overview Table 150. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio Table 152. Changzhou Qianhong Bio-pharma Recent Development Table 153. Hebei Changshan Biochemical Pharmaceutical Company Information Table 154. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 155. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio Table 157. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 158. Beijing SL Pharmaceutical Company Information Table 159. Beijing SL Pharmaceutical Business Overview Table 160. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio Table 162. Beijing SL Pharmaceutical Recent Development Table 163. Huadong Medicine Company Information Table 164. Huadong Medicine Business Overview Table 165. Huadong Medicine Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. Huadong Medicine Enoxaparin Sodium Product Portfolio Table 167. Huadong Medicine Recent Development Table 168. Bharat Serums Company Information Table 169. Bharat Serums Business Overview Table 170. Bharat Serums Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Bharat Serums Enoxaparin Sodium Product Portfolio Table 172. Bharat Serums Recent Development Table 173. INTAS Company Information Table 174. INTAS Business Overview Table 175. INTAS Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. INTAS Enoxaparin Sodium Product Portfolio Table 177. INTAS Recent Development Table 178. LUPIN Company Information Table 179. LUPIN Business Overview Table 180. LUPIN Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 181. LUPIN Enoxaparin Sodium Product Portfolio Table 182. LUPIN Recent Development Table 183. Troikaa Pharmaceuticals Company Information Table 184. Troikaa Pharmaceuticals Business Overview Table 185. Troikaa Pharmaceuticals Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 186. Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio Table 187. Troikaa Pharmaceuticals Recent Development Table 188. Aristopharma Company Information Table 189. Aristopharma Business Overview Table 190. Aristopharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 191. Aristopharma Enoxaparin Sodium Product Portfolio Table 192. Aristopharma Recent Development Table 193. Fosun Pharma Company Information Table 194. Fosun Pharma Business Overview Table 195. Fosun Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 196. Fosun Pharma Enoxaparin Sodium Product Portfolio Table 197. Fosun Pharma Recent Development Table 198. SciencePharma Company Information Table 199. SciencePharma Business Overview Table 200. SciencePharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 201. SciencePharma Enoxaparin Sodium Product Portfolio Table 202. SciencePharma Recent Development Table 203. PISA Company Information Table 204. PISA Business Overview Table 205. PISA Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 206. PISA Enoxaparin Sodium Product Portfolio Table 207. PISA Recent Development Table 208. North America Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 209. North America Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 210. North America Enoxaparin Sodium Sales Market Share by Country (2021-2026) Table 211. North America Enoxaparin Sodium Sales Forecast by Country (2027-2032) & (M Units) Table 212. North America Enoxaparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 213. North America Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 214. North America Enoxaparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 215. North America Enoxaparin Sodium Market Share by Country (2021-2026) Table 216. North America Enoxaparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 217. North America Enoxaparin Sodium Market Share Forecast by Country (2027-2032) Table 218. Europe Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 219. Europe Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 220. Europe Enoxaparin Sodium Sales Market Share by Country (2021-2026) Table 221. Europe Enoxaparin Sodium Sales Forecast by Country (2027-2032) & (M Units) Table 222. Europe Enoxaparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 223. Europe Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 224. Europe Enoxaparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 225. Europe Enoxaparin Sodium Market Share by Country (2021-2026) Table 226. Europe Enoxaparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 227. Europe Enoxaparin Sodium Market Share Forecast by Country (2027-2032) Table 228. Asia-Pacific Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 229. Asia-Pacific Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 230. Asia-Pacific Enoxaparin Sodium Sales Market Share by Country (2021-2026) Table 231. Asia-Pacific Enoxaparin Sodium Sales Forecast by Country (2027-2032) & (M Units) Table 232. Asia-Pacific Enoxaparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 233. Asia-Pacific Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 234. Asia-Pacific Enoxaparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 235. Asia-Pacific Enoxaparin Sodium Market Share by Country (2021-2026) Table 236. Asia-Pacific Enoxaparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 237. Asia-Pacific Enoxaparin Sodium Market Share Forecast by Country (2027-2032) Table 238. Latin America Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 239. Latin America Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 240. Latin America Enoxaparin Sodium Sales Market Share by Country (2021-2026) Table 241. Latin America Enoxaparin Sodium Sales Forecast by Country (2027-2032) & (M Units) Table 242. Latin America Enoxaparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 243. Latin America Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 244. Latin America Enoxaparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 245. Latin America Enoxaparin Sodium Market Share by Country (2021-2026) Table 246. Latin America Enoxaparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 247. Latin America Enoxaparin Sodium Market Share Forecast by Country (2027-2032) Table 248. Middle East and Africa Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 249. Middle East and Africa Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 250. Middle East and Africa Enoxaparin Sodium Sales Market Share by Country (2021-2026) Table 251. Middle East and Africa Enoxaparin Sodium Sales Forecast by Country (2027-2032) & (M Units) Table 252. Middle East and Africa Enoxaparin Sodium Sales Market Share Forecast by Country (2027-2032) Table 253. Middle East and Africa Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 254. Middle East and Africa Enoxaparin Sodium Market Size by Country (2021-2026) & (US$ Million) Table 255. Middle East and Africa Enoxaparin Sodium Market Share by Country (2021-2026) Table 256. Middle East and Africa Enoxaparin Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 257. Middle East and Africa Enoxaparin Sodium Market Share Forecast by Country (2027-2032) Table 258. Key Raw Materials Table 259. Raw Materials Key Suppliers Table 260. Enoxaparin Sodium Distributors List Table 261. Enoxaparin Sodium Customers List Table 262. Research Programs/Design for This Report Table 263. Authors List of This Report Table 264. Secondary Sources Table 265. Primary Sources List of Figures Figure 1. Enoxaparin Sodium Image Figure 2. Global Enoxaparin Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enoxaparin Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Enoxaparin Sodium Sales (2021-2032) & (M Units) Figure 5. 20 mg/0.2mL Image Figure 6. Global 20 mg/0.2mL Sales YoY Growth (2021-2032) & (M Units) Figure 7. 30 mg/0.3mL Image Figure 8. Global 30 mg/0.3mL Sales YoY Growth (2021-2032) & (M Units) Figure 9. 40 mg/0.4mL Image Figure 10. Global 40 mg/0.4mL Sales YoY Growth (2021-2032) & (M Units) Figure 11. 60 mg/0.6mL Image Figure 12. Global 60 mg/0.6mL Sales YoY Growth (2021-2032) & (M Units) Figure 13. 80 mg/0.8mL Image Figure 14. Global 80 mg/0.8mL Sales YoY Growth (2021-2032) & (M Units) Figure 15. 100 mg/1mL Image Figure 16. Global 100 mg/1mL Sales YoY Growth (2021-2032) & (M Units) Figure 17. 120 mg/0.8mL Image Figure 18. Global 120 mg/0.8mL Sales YoY Growth (2021-2032) & (M Units) Figure 19. 150 mg/1mL Image Figure 20. Global 150 mg/1mL Sales YoY Growth (2021-2032) & (M Units) Figure 21. 300mg/3mL Image Figure 22. Global 300mg/3mL Sales YoY Growth (2021-2032) & (M Units) Figure 23. Global Enoxaparin Sodium Market Size Overview by Type (2021-2032) & (US$ Million) Figure 24. Global Enoxaparin Sodium Market Share by Type 2025 VS 2032 Figure 25. North America Enoxaparin Sodium Sales Market Share in Volume by Type in 2025 Figure 26. North America Enoxaparin Sodium Sales Market Share in Value by Type in 2025 Figure 27. Europe Enoxaparin Sodium Sales Market Share in Volume by Type in 2025 Figure 28. Europe Enoxaparin Sodium Sales Market Share in Value by Type in 2025 Figure 29. Asia-Pacific Enoxaparin Sodium Sales Market Share in Volume by Type in 2025 Figure 30. Asia-Pacific Enoxaparin Sodium Sales Market Share in Value by Type in 2025 Figure 31. Latin America Enoxaparin Sodium Sales Market Share in Volume by Type in 2025 Figure 32. Latin America Enoxaparin Sodium Sales Market Share in Value by Type in 2025 Figure 33. Middle East and Africa Enoxaparin Sodium Sales Market Share in Volume by Type in 2025 Figure 34. Middle East and Africa Enoxaparin Sodium Sales Market Share in Value by Type in 2025 Figure 35. Global Top 5 and 10 Enoxaparin Sodium Players Market Share by Revenue in 2025 Figure 36. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 37. Hospital Image Figure 38. Global Hospital Sales YoY Growth (2021-2032) & (M Units) Figure 39. Clinic Image Figure 40. Global Clinic Sales YoY Growth (2021-2032) & (M Units) Figure 41. Others Image Figure 42. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 43. Global Enoxaparin Sodium Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Enoxaparin Sodium Market Share by Application 2025 VS 2032 Figure 45. North America Enoxaparin Sodium Sales Market Share in Volume by Application in 2025 Figure 46. North America Enoxaparin Sodium Sales Market Share in Value by Application in 2025 Figure 47. Europe Enoxaparin Sodium Sales Market Share in Volume by Application in 2025 Figure 48. Europe Enoxaparin Sodium Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Enoxaparin Sodium Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Enoxaparin Sodium Sales Market Share in Value by Application in 2025 Figure 51. Latin America Enoxaparin Sodium Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Enoxaparin Sodium Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Enoxaparin Sodium Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Enoxaparin Sodium Sales Market Share in Value by Application in 2025 Figure 55. North America Enoxaparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 56. North America Enoxaparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Enoxaparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Enoxaparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Enoxaparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 60. Europe Enoxaparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Enoxaparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Enoxaparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Enoxaparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 64. Asia-Pacific Enoxaparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Enoxaparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Enoxaparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Enoxaparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 68. Latin America Enoxaparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Enoxaparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Enoxaparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Enoxaparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 72. Middle East and Africa Enoxaparin Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Enoxaparin Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Enoxaparin Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Enoxaparin Sodium Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Enoxaparin Sodium Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • 20 mg/0.2mL
  • 30 mg/0.3mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 300mg/3mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Teva
  • Techdow (Hepalink)
  • Fresenius Kabi
  • Rovi
  • Amphastar
  • Nanjing King-friend
  • Sandoz
  • Apotex
  • Hangzhou Jiuyuan Gene Engineering
  • Cipla
  • Taj Pharma
  • Chengdu Baiyu Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • Changzhou Qianhong Bio-pharma
  • Hebei Changshan Biochemical Pharmaceutical
  • Beijing SL Pharmaceutical
  • Huadong Medicine
  • Bharat Serums
  • INTAS
  • LUPIN
  • Troikaa Pharmaceuticals
  • Aristopharma
  • Fosun Pharma
  • SciencePharma
  • PISA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enoxaparin Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Enoxaparin Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Enoxaparin Sodium Market by Type
  6. 1.3.1 20 mg/0.2mL
  7. 1.3.2 30 mg/0.3mL
  8. 1.3.3 40 mg/0.4mL
  9. 1.3.4 60 mg/0.6mL
  10. 1.3.5 80 mg/0.8mL
  11. 1.3.6 100 mg/1mL
  12. 1.3.7 120 mg/0.8mL
  13. 1.3.8 150 mg/1mL
  14. 1.3.9 300mg/3mL
  15. 1.4 Global Enoxaparin Sodium Market Size by Type
  16. 1.4.1 Global Enoxaparin Sodium Market Size Overview by Type (2021-2032)
  17. 1.4.2 Global Enoxaparin Sodium Historic Market Size Review by Type (2021-2026)
  18. 1.4.3 Global Enoxaparin Sodium Forecasted Market Size by Type (2027-2032)
  19. 1.5 Key Regions Market Size by Type
  20. 1.5.1 North America Enoxaparin Sodium Sales Breakdown by Type (2021-2026)
  21. 1.5.2 Europe Enoxaparin Sodium Sales Breakdown by Type (2021-2026)
  22. 1.5.3 Asia-Pacific Enoxaparin Sodium Sales Breakdown by Type (2021-2026)
  23. 1.5.4 South America Enoxaparin Sodium Sales Breakdown by Type (2021-2026)
  24. 1.5.5 Middle East and Africa Enoxaparin Sodium Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Enoxaparin Sodium Industry Trends
  2. 2.2 Enoxaparin Sodium Industry Drivers
  3. 2.3 Enoxaparin Sodium Industry Opportunities and Challenges
  4. 2.4 Enoxaparin Sodium Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Enoxaparin Sodium Revenue (2021-2026)
  2. 3.2 Global Top Players by Enoxaparin Sodium Sales (2021-2026)
  3. 3.3 Global Top Players by Enoxaparin Sodium Price (2021-2026)
  4. 3.4 Global Enoxaparin Sodium Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enoxaparin Sodium Major Company Production Sites & Headquarters
  6. 3.6 Global Enoxaparin Sodium Company, Product Type & Application
  7. 3.7 Global Enoxaparin Sodium Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enoxaparin Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enoxaparin Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enoxaparin Sodium Tier 1, Tier 2, and Tier 3
4 Enoxaparin Sodium Regional Status and Outlook
  1. 4.1 Global Enoxaparin Sodium Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Enoxaparin Sodium Historic Market Size by Region
  3. 4.2.1 Global Enoxaparin Sodium Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Enoxaparin Sodium Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Enoxaparin Sodium Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Enoxaparin Sodium Forecasted Market Size by Region
  7. 4.3.1 Global Enoxaparin Sodium Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Enoxaparin Sodium Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Enoxaparin Sodium Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Enoxaparin Sodium by Application
  1. 5.1 Enoxaparin Sodium Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Enoxaparin Sodium Market Size by Application
  6. 5.2.1 Global Enoxaparin Sodium Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Enoxaparin Sodium Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Enoxaparin Sodium Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Enoxaparin Sodium Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Enoxaparin Sodium Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Enoxaparin Sodium Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Enoxaparin Sodium Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Enoxaparin Sodium Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Enoxaparin Sodium Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Enoxaparin Sodium Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Techdow (Hepalink)
  14. 6.3.1 Techdow (Hepalink) Company Information
  15. 6.3.2 Techdow (Hepalink) Business Overview
  16. 6.3.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
  18. 6.3.5 Techdow (Hepalink) Recent Developments
  19. 6.4 Fresenius Kabi
  20. 6.4.1 Fresenius Kabi Company Information
  21. 6.4.2 Fresenius Kabi Business Overview
  22. 6.4.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio
  24. 6.4.5 Fresenius Kabi Recent Developments
  25. 6.5 Rovi
  26. 6.5.1 Rovi Company Information
  27. 6.5.2 Rovi Business Overview
  28. 6.5.3 Rovi Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Rovi Enoxaparin Sodium Product Portfolio
  30. 6.5.5 Rovi Recent Developments
  31. 6.6 Amphastar
  32. 6.6.1 Amphastar Company Information
  33. 6.6.2 Amphastar Business Overview
  34. 6.6.3 Amphastar Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Amphastar Enoxaparin Sodium Product Portfolio
  36. 6.6.5 Amphastar Recent Developments
  37. 6.7 Nanjing King-friend
  38. 6.7.1 Nanjing King-friend Company Information
  39. 6.7.2 Nanjing King-friend Business Overview
  40. 6.7.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio
  42. 6.7.5 Nanjing King-friend Recent Developments
  43. 6.8 Sandoz
  44. 6.8.1 Sandoz Company Information
  45. 6.8.2 Sandoz Business Overview
  46. 6.8.3 Sandoz Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sandoz Enoxaparin Sodium Product Portfolio
  48. 6.8.5 Sandoz Recent Developments
  49. 6.9 Apotex
  50. 6.9.1 Apotex Company Information
  51. 6.9.2 Apotex Business Overview
  52. 6.9.3 Apotex Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Apotex Enoxaparin Sodium Product Portfolio
  54. 6.9.5 Apotex Recent Developments
  55. 6.10 Hangzhou Jiuyuan Gene Engineering
  56. 6.10.1 Hangzhou Jiuyuan Gene Engineering Company Information
  57. 6.10.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  58. 6.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
  60. 6.10.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  61. 6.11 Cipla
  62. 6.11.1 Cipla Company Information
  63. 6.11.2 Cipla Business Overview
  64. 6.11.3 Cipla Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cipla Enoxaparin Sodium Product Portfolio
  66. 6.11.5 Cipla Recent Developments
  67. 6.12 Taj Pharma
  68. 6.12.1 Taj Pharma Company Information
  69. 6.12.2 Taj Pharma Business Overview
  70. 6.12.3 Taj Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Taj Pharma Enoxaparin Sodium Product Portfolio
  72. 6.12.5 Taj Pharma Recent Developments
  73. 6.13 Chengdu Baiyu Pharmaceutical
  74. 6.13.1 Chengdu Baiyu Pharmaceutical Company Information
  75. 6.13.2 Chengdu Baiyu Pharmaceutical Business Overview
  76. 6.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
  78. 6.13.5 Chengdu Baiyu Pharmaceutical Recent Developments
  79. 6.14 Suzhou Erye Pharmaceutical
  80. 6.14.1 Suzhou Erye Pharmaceutical Company Information
  81. 6.14.2 Suzhou Erye Pharmaceutical Business Overview
  82. 6.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
  84. 6.14.5 Suzhou Erye Pharmaceutical Recent Developments
  85. 6.15 Changzhou Qianhong Bio-pharma
  86. 6.15.1 Changzhou Qianhong Bio-pharma Company Information
  87. 6.15.2 Changzhou Qianhong Bio-pharma Business Overview
  88. 6.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
  90. 6.15.5 Changzhou Qianhong Bio-pharma Recent Developments
  91. 6.16 Hebei Changshan Biochemical Pharmaceutical
  92. 6.16.1 Hebei Changshan Biochemical Pharmaceutical Company Information
  93. 6.16.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
  94. 6.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
  96. 6.16.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  97. 6.17 Beijing SL Pharmaceutical
  98. 6.17.1 Beijing SL Pharmaceutical Company Information
  99. 6.17.2 Beijing SL Pharmaceutical Business Overview
  100. 6.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
  102. 6.17.5 Beijing SL Pharmaceutical Recent Developments
  103. 6.18 Huadong Medicine
  104. 6.18.1 Huadong Medicine Company Information
  105. 6.18.2 Huadong Medicine Business Overview
  106. 6.18.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Huadong Medicine Enoxaparin Sodium Product Portfolio
  108. 6.18.5 Huadong Medicine Recent Developments
  109. 6.19 Bharat Serums
  110. 6.19.1 Bharat Serums Company Information
  111. 6.19.2 Bharat Serums Business Overview
  112. 6.19.3 Bharat Serums Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Bharat Serums Enoxaparin Sodium Product Portfolio
  114. 6.19.5 Bharat Serums Recent Developments
  115. 6.20 INTAS
  116. 6.20.1 INTAS Company Information
  117. 6.20.2 INTAS Business Overview
  118. 6.20.3 INTAS Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 INTAS Enoxaparin Sodium Product Portfolio
  120. 6.20.5 INTAS Recent Developments
  121. 6.21 LUPIN
  122. 6.21.1 LUPIN Company Information
  123. 6.21.2 LUPIN Business Overview
  124. 6.21.3 LUPIN Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 LUPIN Enoxaparin Sodium Product Portfolio
  126. 6.21.5 LUPIN Recent Developments
  127. 6.22 Troikaa Pharmaceuticals
  128. 6.22.1 Troikaa Pharmaceuticals Company Information
  129. 6.22.2 Troikaa Pharmaceuticals Business Overview
  130. 6.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
  132. 6.22.5 Troikaa Pharmaceuticals Recent Developments
  133. 6.23 Aristopharma
  134. 6.23.1 Aristopharma Company Information
  135. 6.23.2 Aristopharma Business Overview
  136. 6.23.3 Aristopharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Aristopharma Enoxaparin Sodium Product Portfolio
  138. 6.23.5 Aristopharma Recent Developments
  139. 6.24 Fosun Pharma
  140. 6.24.1 Fosun Pharma Company Information
  141. 6.24.2 Fosun Pharma Business Overview
  142. 6.24.3 Fosun Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Fosun Pharma Enoxaparin Sodium Product Portfolio
  144. 6.24.5 Fosun Pharma Recent Developments
  145. 6.25 SciencePharma
  146. 6.25.1 SciencePharma Company Information
  147. 6.25.2 SciencePharma Business Overview
  148. 6.25.3 SciencePharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 SciencePharma Enoxaparin Sodium Product Portfolio
  150. 6.25.5 SciencePharma Recent Developments
  151. 6.26 PISA
  152. 6.26.1 PISA Company Information
  153. 6.26.2 PISA Business Overview
  154. 6.26.3 PISA Enoxaparin Sodium Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 PISA Enoxaparin Sodium Product Portfolio
  156. 6.26.5 PISA Recent Developments
7 North America by Country
  1. 7.1 North America Enoxaparin Sodium Sales by Country
  2. 7.1.1 North America Enoxaparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Enoxaparin Sodium Sales by Country (2021-2026)
  4. 7.1.3 North America Enoxaparin Sodium Sales Forecast by Country (2027-2032)
  5. 7.2 North America Enoxaparin Sodium Market Size by Country
  6. 7.2.1 North America Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Enoxaparin Sodium Market Size by Country (2021-2026)
  8. 7.2.3 North America Enoxaparin Sodium Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Enoxaparin Sodium Sales by Country
  2. 8.1.1 Europe Enoxaparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Enoxaparin Sodium Sales by Country (2021-2026)
  4. 8.1.3 Europe Enoxaparin Sodium Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Enoxaparin Sodium Market Size by Country
  6. 8.2.1 Europe Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Enoxaparin Sodium Market Size by Country (2021-2026)
  8. 8.2.3 Europe Enoxaparin Sodium Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Enoxaparin Sodium Sales by Country
  2. 9.1.1 Asia-Pacific Enoxaparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Enoxaparin Sodium Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Enoxaparin Sodium Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Enoxaparin Sodium Market Size by Country
  6. 9.2.1 Asia-Pacific Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Enoxaparin Sodium Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Enoxaparin Sodium Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Enoxaparin Sodium Sales by Country
  2. 10.1.1 South America Enoxaparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Enoxaparin Sodium Sales by Country (2021-2026)
  4. 10.1.3 South America Enoxaparin Sodium Sales Forecast by Country (2027-2032)
  5. 10.2 South America Enoxaparin Sodium Market Size by Country
  6. 10.2.1 South America Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Enoxaparin Sodium Market Size by Country (2021-2026)
  8. 10.2.3 South America Enoxaparin Sodium Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Enoxaparin Sodium Sales by Country
  2. 11.1.1 Middle East and Africa Enoxaparin Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Enoxaparin Sodium Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Enoxaparin Sodium Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Enoxaparin Sodium Market Size by Country
  6. 11.2.1 Middle East and Africa Enoxaparin Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Enoxaparin Sodium Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Enoxaparin Sodium Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Enoxaparin Sodium Value Chain Analysis
  2. 12.1.1 Enoxaparin Sodium Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Enoxaparin Sodium Production Mode & Process
  7. 12.2 Enoxaparin Sodium Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Enoxaparin Sodium Distributors
  10. 12.2.3 Enoxaparin Sodium Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst